SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (312)2/19/1997 10:34:00 AM
From: Pete Holm   of 6136
 
Absolutely Fantastic News out today. AGPH filed in Europe. Europe has always been much faster in approving new drugs than the FDA. Additionally, in Europe, Viracept will be sold by Roche with their 1000 salespeople. They also have well established contacts in the AIDS market.

Does anyone know if Roche or Japan Tobbacco will be selling it in Africa? This is probably a billion plus market for them.

A friend of mine bumped into a AGPH salesrep. They are out taking stocking orders and plan a full launch the first or second week of March in the US. They are also averaging 50 new patients per week on their expanded access program. They were told, back when it hit 90, that a three for one stock split is coming.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News